Compare PRTH & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTH | BWAY |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | Israel |
| Employees | 1200 | 129 |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.9M | 578.5M |
| IPO Year | N/A | N/A |
| Metric | PRTH | BWAY |
|---|---|---|
| Price | $6.20 | $14.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.33 | ★ $13.25 |
| AVG Volume (30 Days) | ★ 202.9K | 122.7K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.76 | $309.69 |
| Revenue Next Year | $6.79 | $26.21 |
| P/E Ratio | ★ $10.38 | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.44 | $10.81 |
| 52 Week High | $8.89 | $26.63 |
| Indicator | PRTH | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 45.14 |
| Support Level | $5.33 | $14.53 |
| Resistance Level | $6.75 | $14.65 |
| Average True Range (ATR) | 0.28 | 0.60 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 49.52 | 35.17 |
Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.